(NASDAQ: MDLN) Medline's forecast annual revenue growth rate of 9.33% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 11.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.54%.
Medline's revenue in 2026 is $28,432,000,000.On average, 29 Wall Street analysts forecast MDLN's revenue for 2026 to be $41,397,106,798,944, with the lowest MDLN revenue forecast at $39,350,372,463,048, and the highest MDLN revenue forecast at $42,926,245,930,512. On average, 29 Wall Street analysts forecast MDLN's revenue for 2027 to be $44,577,558,549,396, with the lowest MDLN revenue forecast at $42,277,281,384,984, and the highest MDLN revenue forecast at $46,749,093,759,432.
In 2028, MDLN is forecast to generate $47,994,475,114,008 in revenue, with the lowest revenue forecast at $45,254,110,656,576 and the highest revenue forecast at $50,959,481,144,892.